Request for Information on the FY 2013-2018 Strategic Plan for the Office of Disease Prevention, 15960-15961 [2013-05773]

Download as PDF 15960 Federal Register / Vol. 78, No. 49 / Wednesday, March 13, 2013 / Notices ESTIMATED ANNUALIZED BURDEN HOURS Type of respondent Number of respondents Number of responses per respondent Average time per response (in hours) Total annual burden hour Applicants ........................................................................................................ 1,560 1 25/60 650 Dated: February 1, 2013. Timothy J. Tosten, Executive Officer, Deputy Ethics Counselor, Director, Division of Management Services, Center for Scientific Review, NIH. [FR Doc. 2013–05776 Filed 3–12–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Request for Information on the FY 2013–2018 Strategic Plan for the Office of Disease Prevention The purpose of this Request for Information (RFI) is to seek broad public input on the Fiscal Year (FY) 2013–2018 Strategic Plan for the Office of Disease Prevention (ODP), National Institutes of Health (NIH). DATES: To ensure consideration, responses must be received by April 14, 2013. ADDRESSES: Comments must be submitted electronically using the webbased form available at http:// prevention.nih.gov/aboutus/ strategic_plan/rfi.aspx. FOR FURTHER INFORMATION CONTACT: Please direct all inquiries to Wilma Peterman Cross, M.S.; Senior Public Health Advisor, Office of Disease Prevention, National Institutes of Health; phone: 301–496–1508; email: prevention@mail.nih.gov. SUMMARY: The mission of ODP is to improve the public health by increasing the scope, quality, dissemination, and impact of prevention research supported by the NIH. ODP will fulfill this mission by providing leadership for the development, coordination, and implementation of prevention research in collaboration with the NIH Institutes and Centers (ICs) and other partners. The Office is responsible for advising the Director, NIH, regarding prevention research issues, actions, and activities. The Office also provides overall guidance to the ICs on biomedical programs that seek to improve the nation’s health through research, training, knowledge translation, and public education as mstockstill on DSK4VPTVN1PROD with NOTICES SUPPLEMENTARY INFORMATION: VerDate Mar<15>2010 17:11 Mar 12, 2013 Jkt 229001 they relate to health promotion and disease prevention. Prevention research at the NIH encompasses research designed both to promote health and to prevent the onset of disease, disorders, or injuries and the progression of asymptomatic disease. Prevention research targets biology and genetics, individual behavior, factors in the social and physical environments, and health services; and it informs and evaluates health-related policies and regulations. Prevention research includes: • Identification and assessment of risk and protective factors. • Screening and identification of individuals and groups at risk. • Development and evaluation of interventions to reduce risk. • Translation and dissemination of effective preventive interventions into practice. • Development of research methods to support this work. The Office was established in 1986 in response to a directive in the Health Research Extension Act of 1985. With increased attention on the application of prevention research nationally and the recent reorganization of ODP, the Office has embarked on an extensive planning process to develop a strategic plan for FY 2013–2018. Information Requested This RFI is intended to gather broad public input on the strategic priorities to be included in the plan and other suggestions on how to enhance the prevention research portfolio at the NIH. The ODP invites input from prevention researchers in academia and industry; from health care professionals, patient advocates and advocacy organizations, scientific or professional organizations, federal agencies; and from other interested members of the public. Organizations are strongly encouraged to submit a single response that reflects the views of their organization and membership as a whole. Your perspectives can include, but are not limited to, the following topics as they relate to the six draft strategic priorities listed below: • Suggested changes, additions, or deletions to the list of strategic priorities PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 • Recommended measurable objectives associated with an individual priority • Appropriate benchmarks for gauging progress toward each recommended objective. Strategic Priority #1: Systematically monitor NIH investments in prevention research and the progress and results of that research. Strategic Priority #2: Identify and promote prevention research areas that deserve expanded effort and investment by the NIH. Strategic Priority #3: Promote the use of the best available methods in prevention research and support the development of new and innovative approaches. Strategic Priority #4: Encourage development of collaborative prevention research projects and facilitate coordination of such projects across the NIH and with other public and private entities. Strategic Priority #5: Identify and promote the use of effective evidencebased interventions. Strategic Priority #6: Increase the visibility of prevention research at the NIH and across the country. In addition to the strategic priorities, the ODP welcomes suggestions on how to enhance the prevention research portfolio at the NIH: 1. Suggested changes to the approach used by the NIH to develop funding opportunity announcements that could improve the quality of prevention research supported by the NIH. 2. Suggested changes to the approach used by the NIH to review applications that could improve the quality of prevention research supported by the NIH. 3. Suggested changes to the approach used by the NIH in managing funded projects that could improve the quality of prevention research supported by the NIH. How To Submit a Response To ensure consideration, responses must be received by April 14, 2013, and should be submitted electronically using the web-based form available at http://prevention.nih.gov/aboutus/ strategic_plan/rfi.aspx. The web form will provide confirmation of response E:\FR\FM\13MRN1.SGM 13MRN1 Federal Register / Vol. 78, No. 49 / Wednesday, March 13, 2013 / Notices submission, but respondents will not receive individualized feedback. All respondents are encouraged to sign up for the ODP email list at http:// prevention-nih.org/subscribe to receive information related to Office activities, including updates on the development and release of the final strategic plan. Responses to this RFI are voluntary and may be submitted anonymously. Please do not include any personally identifiable or other information that you do not wish to make public. Proprietary, classified, confidential, or sensitive information should not be included in responses. Comments submitted will be compiled for discussion and incorporated into the ODP strategic plan as appropriate. Any personal identifiers (personal names, email addresses, etc.) will be removed when responses are compiled. This RFI is for informational and planning purposes only and is not a solicitation for applications or an obligation on the part of the United States Government to provide support for any ideas identified in response to it. Please note that the U.S. Government will not pay for the preparation of any information submitted or for use of that information. Dated: February 5, 2013. Francis S. Collins, Director, National Institutes of Health. [FR Doc. 2013–05773 Filed 3–12–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration mstockstill on DSK4VPTVN1PROD with NOTICES Center for Substance Abuse Treatment National Advisory Council; Meeting Pursuant to Public Law 92–463, notice is hereby given of the meeting of the Substance Abuse and Mental Health Services Administration’s (SAMHSA) Center for Substance Abuse Treatment National Advisory Council on April 10, 2013. The meeting is open to the public and will include a discussion of the Center’s current administrative, legislative, and program developments. Public comments are welcome. To attend onsite, or request special accommodations for persons with disabilities, please register at SAMHSA Committees’ Web site, http://nac.samhsa.gov/ Registration/meetingsRegistration.aspx, or contact the Council’s Designated Federal Officer, Ms. Cynthia Graham (see contact information below). VerDate Mar<15>2010 17:11 Mar 12, 2013 Jkt 229001 Committee Name: Substance Abuse and Mental Health Services Administration Center for Substance Abuse Treatment National Advisory Council. Date/Time/Type: April 10, 2013 9:00 a.m.– 4:30 p.m. (OPEN). Place: SAMHSA, 1 Choke Cherry Road, Sugarloaf Conference Room, Rockville, MD 20857. Contact: Cynthia Graham, M.S., Designated Federal Official, SAMHSA/CSAT National Advisory Council, 1 Choke Cherry Road, Room 5–1035, Rockville, MD 20857, Telephone: (240) 276–1692, FAX: (240) 276– 1690, Email: cynthia.graham@samhsa.hhs.gov. Cathy J. Friedman, Public Health Analyst, SAMHSA. [FR Doc. 2013–05407 Filed 3–12–13; 8:45 am] BILLING CODE 4162–20–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration National Advisory Council; Notice of Meeting Pursuant to Public Law 92–463, notice is hereby given of a meeting of the Substance Abuse and Mental Health Services Administration’s (SAMHSA) National Advisory Council (NAC) on April 12, 2013. The meeting will include a recap of the April 11, 2013 Joint Council meeting, and discussions of the National Behavioral Health Quality Framework and Barometer, National Dialogue, and prescription drug abuse. The meeting is open to the public and will be held at the SAMHSA building, 1 Choke Cherry Road, Rockville, MD 20857 in the Sugarloaf Conference Room. Attendance by the public will be limited to space available. Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee. Written submissions should be forwarded to the contact person on or before one week prior to the meeting. Oral presentations from the public will be scheduled at the conclusion of the meeting. Individuals interested in making oral presentations are encouraged to notify the contact on or before one week prior to the meeting. Five minutes will be allotted for each presentation. The meeting may be accessed via teleconference. To attend on site, obtain the call-in number and access code, submit written or brief oral comments, or request special accommodations for persons with disabilities, please register on-line at http://nac.samhsa.gov/ Registration/meetingsRegistration.aspx, PO 00000 Frm 00034 Fmt 4703 Sfmt 4703 15961 or communicate with SAMHSA’s Committee Management Officer, Ms. Geretta Wood (see contact information below). Substantive meeting information and a roster of Committee members may be obtained either by accessing the SAMHSA Committees’ Web site at https://nac.samhsa.gov/ WomenServices/index.aspx, or by contacting Ms. Wood. The transcript for the meeting will be available on the SAMHSA Committees’ Web site within three weeks after the meeting. Committee Name: SAMHSA’s National Advisory Council. Date/Time/Type: Friday, April 12, 2013 from 9 a.m. to 3:30 EDT: OPEN. Place: SAMHSA, 1 Choke Cherry Road, SAMHSA Sugarloaf Conference Room, Rockville, Maryland 20857. Contact: Geretta Wood, Committee Management Officer and Designated Federal Official of the SAMHSA National Advisory Council and SAMHSA’s Advisory Committee for Women’s Services, 1 Choke Cherry Road, Rockville, Maryland 20857, Telephone: (240) 276–2326, Fax: (240) 276–2252 and Email: geretta.wood@samhsa.hhs.gov. Cathy J. Friedman, Public Health Analyst, SAMHSA. [FR Doc. 2013–05757 Filed 3–12–13; 8:45 am] BILLING CODE 4162–20–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Notice of Meeting Pursuant to Public Law 92–463, notice is hereby given of the combined meeting on April 11, 2013, of the Substance Abuse and Mental Health Services Administration’s (SAMHSA) four National Advisory Councils (the SAMHSA National Advisory Council (NAC), the Center for Mental Health Services NAC, the Center for Substance Abuse Prevention NAC, the Center for Substance Abuse Treatment NAC), and the two SAMHSA Advisory Committees (Advisory Committee for Women’s Services, and the Tribal Technical Advisory Committee). The Councils were established to advise the Secretary, Department of Health and Human Services (HHS), the Administrator, SAMHSA, and Center Directors, concerning matters relating to the activities carried out by and through the Centers and the policies respecting such activities. Under Section 501 of the Public Health Service Act, the Advisory Committee for Women’s Services (ACWS) is statutorily mandated to E:\FR\FM\13MRN1.SGM 13MRN1

Agencies

[Federal Register Volume 78, Number 49 (Wednesday, March 13, 2013)]
[Notices]
[Pages 15960-15961]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-05773]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Request for Information on the FY 2013-2018 Strategic Plan for 
the Office of Disease Prevention

SUMMARY: The purpose of this Request for Information (RFI) is to seek 
broad public input on the Fiscal Year (FY) 2013-2018 Strategic Plan for 
the Office of Disease Prevention (ODP), National Institutes of Health 
(NIH).

DATES: To ensure consideration, responses must be received by April 14, 
2013.

ADDRESSES: Comments must be submitted electronically using the web-
based form available at http://prevention.nih.gov/aboutus/strategic_plan/rfi.aspx.

FOR FURTHER INFORMATION CONTACT: Please direct all inquiries to Wilma 
Peterman Cross, M.S.; Senior Public Health Advisor, Office of Disease 
Prevention, National Institutes of Health; phone: 301-496-1508; email: 
prevention@mail.nih.gov.

SUPPLEMENTARY INFORMATION: The mission of ODP is to improve the public 
health by increasing the scope, quality, dissemination, and impact of 
prevention research supported by the NIH. ODP will fulfill this mission 
by providing leadership for the development, coordination, and 
implementation of prevention research in collaboration with the NIH 
Institutes and Centers (ICs) and other partners. The Office is 
responsible for advising the Director, NIH, regarding prevention 
research issues, actions, and activities. The Office also provides 
overall guidance to the ICs on biomedical programs that seek to improve 
the nation's health through research, training, knowledge translation, 
and public education as they relate to health promotion and disease 
prevention.
    Prevention research at the NIH encompasses research designed both 
to promote health and to prevent the onset of disease, disorders, or 
injuries and the progression of asymptomatic disease. Prevention 
research targets biology and genetics, individual behavior, factors in 
the social and physical environments, and health services; and it 
informs and evaluates health-related policies and regulations. 
Prevention research includes:
     Identification and assessment of risk and protective 
factors.
     Screening and identification of individuals and groups at 
risk.
     Development and evaluation of interventions to reduce 
risk.
     Translation and dissemination of effective preventive 
interventions into practice.
     Development of research methods to support this work.
    The Office was established in 1986 in response to a directive in 
the Health Research Extension Act of 1985. With increased attention on 
the application of prevention research nationally and the recent 
reorganization of ODP, the Office has embarked on an extensive planning 
process to develop a strategic plan for FY 2013-2018.

Information Requested

    This RFI is intended to gather broad public input on the strategic 
priorities to be included in the plan and other suggestions on how to 
enhance the prevention research portfolio at the NIH. The ODP invites 
input from prevention researchers in academia and industry; from health 
care professionals, patient advocates and advocacy organizations, 
scientific or professional organizations, federal agencies; and from 
other interested members of the public. Organizations are strongly 
encouraged to submit a single response that reflects the views of their 
organization and membership as a whole.
    Your perspectives can include, but are not limited to, the 
following topics as they relate to the six draft strategic priorities 
listed below:
     Suggested changes, additions, or deletions to the list of 
strategic priorities
     Recommended measurable objectives associated with an 
individual priority
     Appropriate benchmarks for gauging progress toward each 
recommended objective.
    Strategic Priority #1: Systematically monitor NIH investments in 
prevention research and the progress and results of that research.
    Strategic Priority #2: Identify and promote prevention research 
areas that deserve expanded effort and investment by the NIH.
    Strategic Priority #3: Promote the use of the best available 
methods in prevention research and support the development of new and 
innovative approaches.
    Strategic Priority #4: Encourage development of collaborative 
prevention research projects and facilitate coordination of such 
projects across the NIH and with other public and private entities.
    Strategic Priority #5: Identify and promote the use of effective 
evidence-based interventions.
    Strategic Priority #6: Increase the visibility of prevention 
research at the NIH and across the country.
    In addition to the strategic priorities, the ODP welcomes 
suggestions on how to enhance the prevention research portfolio at the 
NIH:
    1. Suggested changes to the approach used by the NIH to develop 
funding opportunity announcements that could improve the quality of 
prevention research supported by the NIH.
    2. Suggested changes to the approach used by the NIH to review 
applications that could improve the quality of prevention research 
supported by the NIH.
    3. Suggested changes to the approach used by the NIH in managing 
funded projects that could improve the quality of prevention research 
supported by the NIH.

How To Submit a Response

    To ensure consideration, responses must be received by April 14, 
2013, and should be submitted electronically using the web-based form 
available at http://prevention.nih.gov/aboutus/strategic_plan/rfi.aspx. The web form will provide confirmation of response

[[Page 15961]]

submission, but respondents will not receive individualized feedback. 
All respondents are encouraged to sign up for the ODP email list at 
http://prevention-nih.org/subscribe to receive information related to 
Office activities, including updates on the development and release of 
the final strategic plan. Responses to this RFI are voluntary and may 
be submitted anonymously. Please do not include any personally 
identifiable or other information that you do not wish to make public. 
Proprietary, classified, confidential, or sensitive information should 
not be included in responses. Comments submitted will be compiled for 
discussion and incorporated into the ODP strategic plan as appropriate. 
Any personal identifiers (personal names, email addresses, etc.) will 
be removed when responses are compiled. This RFI is for informational 
and planning purposes only and is not a solicitation for applications 
or an obligation on the part of the United States Government to provide 
support for any ideas identified in response to it. Please note that 
the U.S. Government will not pay for the preparation of any information 
submitted or for use of that information.

    Dated: February 5, 2013.
Francis S. Collins,
Director, National Institutes of Health.
[FR Doc. 2013-05773 Filed 3-12-13; 8:45 am]
BILLING CODE 4140-01-P